Biomarkers of Lung Injury in Critical Care Medicine: Past, Present, and Future

REFERENCES

• Bajaj, M. S., Tricomi, S. M. (1999). Plasma levels of the three endothelial-specific proteins von willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intens. Care Med. 25(11): 1259–1266.
   PubMed Web of Science ®Google Scholar
• Bajwa, E. K., Khan, U. A., Januzzi, J. L., Gong, M. N., Thompson, B. T., Christiani, D. C. (2009). Plasma c-reactive protein levels are associated with improved outcome in ards. Chest 136(2): 471–480.
   Google Scholar
• Barnett, N., Ware, L. B. (2011). Biomarkers in acute lung injury–marking forward progress. Crit. Care Clin. 27(3): 661–683.
   Google Scholar
• Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., Spragg, R. (1994). Report of the American-European Consensus Conference on Acute Respiratory Distress Syndrome: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J. Crit. Care 9(1): 72–81.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3): 89–95.
   PubMed Web of Science ®Google Scholar
• Bonniaud, P., Margetts, P. J., Ask, K., Flanders, K., Gauldie, J., Kolb, M. (2005). Tgf-beta and smad3 signaling link inflammation to chronic fibrogenesis. J. Immunol. 175(8): 5390–5395.
   PubMed Web of Science ®Google Scholar
• Broeckaert, F., Bernard, A. (2000). Clara cell secretory protein (cc16): Characteristics and perspectives as lung peripheral biomarker. Clin. Exp. Allergy 30(4): 469–475.
   PubMed Web of Science ®Google Scholar
• Calfee, C. S., Eisner, M. D., Parsons, P. E., Thompson, B. T., Conner, E. R., Jr., Matthay, M. A., Ware, L. B. (2009). Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intens. Care Med. 35(2): 248–257.
   PubMedGoogle Scholar
• Calfee, C. S., Ware, L. B., Eisner, M. D., Parsons, P. E., Thompson, B. T., Wickersham, N., and Matthay, M. A. (2008). Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63(12): 1083–1089.
   PubMed Web of Science ®Google Scholar
• Cross, L. J., and Matthay, M. A. (2011). Biomarkers in acute lung injury: Insights into the pathogenesis of acute lung injury. Crit. Care Clin. 27(2): 355–377.
   PubMed Web of Science ®Google Scholar
• Dada, L. A., and Sznajder, J. I. (2007). Hypoxic inhibition of alveolar fluid reabsorption. Adv. Exp. Med. Biol. 618: 159–168.
   Google Scholar
• Determann, R. M., Millo, J. L., Waddy, S., Lutter, R., Garrard, C. S., Schultz, M. J. (2009). Plasma cc16 levels are associated with development of ali/ards in patients with ventilator-associated pneumonia: A retrospective observational study. BMC Pulm. Med. 9: 49.
   PubMedGoogle Scholar
• Dos Santos, G., Kutuzov, M. A., Ridge, K. M. (2012). The inflammasome in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 303(8): L627–L633.
   Google Scholar
• Durr, U. H., Waskell, L., Ramamoorthy, A. (2007). The cytochromes p450 and b5 and their reductases–promising targets for structural studies by advanced solid-state nmr spectroscopy. Biochim. Biophys. Acta 1768(12): 3235–3259.
   Google Scholar
• Eisner, M. D., Parsons, P., Matthay, M. A., Ware, L., Greene, K. (2003). “Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.” Thorax 58(11): 983–988.
   PubMed Web of Science ®Google Scholar
• Fan, J., Ye, R.D., Malik, A.B. (2001). Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 281(5): L1037–1050.
   Google Scholar
• Flori, H. R., Ware, L. B., Glidden, D., Matthay, M. A. (2003). Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr. Crit. Care Med. 4(3): 315–321.
   PubMedGoogle Scholar
• Gallagher, D. C., Parikh, S. M., Balonov, K., Miller, A., Gautam, S., Talmor, D., Sukhatme, V. P. (2008). Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 29(6): 656–661.
   PubMed Web of Science ®Google Scholar
• Ganter, M. T., Roux, J., Miyazawa, B., Howard, M., Frank, J. A., Su, G., Sheppard, D., Violette, S. M., Weinreb, P. H., Horan, G. S., Matthay, M. A., Pittet, J. F. (2008). Interleukin-1beta causes acute lung injury via #v#5 and #v#6 integrin-dependent mechanisms. Circ. Res. 102(7): 804–812.
   Google Scholar
• Gerlach, H., Toussaint, S. (2011). Sensitive, specific, predictive . . . Statistical basics: How to use biomarkers. Crit. Care Clin. 27(2): 215–227.
   Google Scholar
• Greene, K. E., Wright, J. R., Steinberg, K. P., Ruzinski, J. T., Caldwell, E., Wong, W. B., Hull, W., Whitsett, J. A., Akino, T., Kuroki, Y., Nagae, H., Hudson, L. D., Martin, T. R. (1999). Serial changes in surfactant-associated proteins in lung and serum before and after onset of ards. Am. J. Respir. Crit. Care Med. 160(6): 1843–1850.
   PubMed Web of Science ®Google Scholar
• Howrylak, J. A., Dolinay, T., Lucht, L., Wang, Z., Christiani, D. C., Sethi, J. M., Xing, E. P., Donahoe, M. P., Choi, A. M. (2009). Discovery of the gene signature for acute lung injury in patients with sepsis. Physiol. Genomics 37(2): 133–139.
   PubMedGoogle Scholar
• Idell, S. (2003). Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 31(4 Suppl): S213–220.
   PubMed Web of Science ®Google Scholar
• Ishizaka, A., Matsuda, T., Albertine, K. H., Koh, H., Tasaka, S., Hasegawa, N., Kohno, N., Kotani, T., Morisaki, H., Takeda, J., Nakamura, M., Fang, X., Martin, T. R., Matthay, M. A., Hashimoto, S. (2004). Elevation of kl-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 286(6): L1088–1094.
   PubMed Web of Science ®Google Scholar
• Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., Gauldie, J. (2001). Transient expression of il-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107(12): 1529–1536.
   PubMed Web of Science ®Google Scholar
• Kropski, J. A., Fremont, R. D., Calfee, C. S., Ware, L. B. (2009). Clara cell protein (cc16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 135(6): 1440–1447.
   PubMedGoogle Scholar
• Lesur, O., Langevin, S., Berthiaume, Y., Legare, M., Skrobik, Y., Bellemare, J. F., Levy, B., Fortier, Y., Lauzier, F., Bravo, G., Nickmilder, M., Rousseau, E., Bernard, A. (2006). Outcome value of clara cell protein in serum of patients with acute respiratory distress syndrome. Intens. Care Med. 32(8): 1167–1174.
   PubMed Web of Science ®Google Scholar
• Lin, W. C., Lin, C. F., Chen, C. L., Chen, C. W., and Lin, Y. S. (2010). “Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators.” Exp. Biol. Med. (Maywood) 235(1): 57–65.
   Google Scholar
• Mcclintock, D., Zhuo, H., Wickersham, N., Matthay, M. A., Ware, L. B. (2008). Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit. Care 12(2): R41.
   PubMed Web of Science ®Google Scholar
• Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., Leeper, K. (1995a). Persistent elevation of inflammatory cytokines predicts a poor outcome in ards. Plasma il-1 beta and il-6 levels are consistent and efficient predictors of outcome over time. Chest 107(4): 1062–1073.
   PubMed Web of Science ®Google Scholar
• Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., Postlethwaite, A. (1995b). Inflammatory cytokines in the bal of patients with ards. Persistent elevation over time predicts poor outcome. Chest 108(5): 1303–1314.
   PubMed Web of Science ®Google Scholar
• Menoret, A., Kumar, S., Vella, A. T. (2012). Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS One 7(7): e40184.
   Google Scholar
• Moss, M., Ackerson, L., Gillespie, M. K., Moore, F. A., Moore, E. E., Parsons, P. E. (1995). Von willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151(1): 15–20.
   PubMed Web of Science ®Google Scholar
• Muller, W. A. (2009). “Mechanisms of transendothelial migration of leukocytes.” Circ Res 105(3): 223–230.
   PubMed Web of Science ®Google Scholar
• Nader, N. D., Mcquiller, P. S., Raghavendran, K., Spengler, R. N., and Knight, P. R. (2007). The role of alveolar macrophages in the pathogenesis of aspiration pneumonitis. Immunol Invest. 36(4): 457–471.
   PubMed Web of Science ®Google Scholar
• Park, W. Y., Goodman, R. B., Steinberg, K. P., Ruzinski, J. T., Radella, F., 2nd, Park, D. R., Pugin, J., Skerrett, S. J., Hudson, L. D., Martin, T. R. (2001). Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 164(10 Pt 1): 1896–1903.
   PubMed Web of Science ®Google Scholar
• Parsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M., Bernard, G. R., Wheeler, A. P. (2005a). Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 33(1): 1–6; discussion 230–232.
   PubMed Web of Science ®Google Scholar
• Parsons, P. E., Matthay, M. A., Ware, L. B., Eisner, M. D. (2005b). Elevated plasma levels of soluble tnf receptors are associated with morbidity and mortality in patients with acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 288(3): L426–431.
   PubMed Web of Science ®Google Scholar
• Prabhakaran, P., Ware, L. B., White, K. E., Cross, M. T., Matthay, M. A., Olman, M. A. (2003). Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 285(1): L20–28.
   PubMed Web of Science ®Google Scholar
• Pugin, J., Ricou, B., Steinberg, K. P., Suter, P. M., Martin, T. R. (1996). Proinflammatory activity in bronchoalveolar lavage fluids from patients with ards, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153(6 Pt 1): 1850–1856.
   PubMed Web of Science ®Google Scholar
• Pugin, J., Verghese, G., Widmer, M. C., Matthay, M. A. (1999). “The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 27(2): 304–312.
   PubMed Web of Science ®Google Scholar
• Ranieri, V. M., Rubenfeld, G. D., Thompson, B. T., Ferguson, N. D., Caldwell, E., Fan, E., Camporota, L., Slutsky, A. S. (2012). Acute respiratory distress syndrome: The Berlin definition. JAMA 307(23): 2526–2533.
   PubMed Web of Science ®Google Scholar
• Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., Hudson, L. D. (2005). Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353(16): 1685–1693.
   PubMed Web of Science ®Google Scholar
• Rubenfeld, G. D., Herridge, M. S. (2007). Epidemiology and outcomes of acute lung injury. Chest 131(2): 554–562.
   PubMed Web of Science ®Google Scholar
• Schenkman, J. B., Jansson, I. (2003). The many roles of cytochrome b5. Pharmacol. Ther. 97(2): 139–152.
   PubMed Web of Science ®Google Scholar
• Schnapp, L. M., Donohoe, S., Chen, J., Sunde, D. A., Kelly, P. M., Ruzinski, J., Martin, T., Goodlett, D. R. (2006). Mining the acute respiratory distress syndrome proteome: Identification of the insulin-like growth factor (igf)/igf-binding protein-3 pathway in acute lung injury. Am. J. Pathol. 169(1): 86–95.
   PubMed Web of Science ®Google Scholar
• Schottelius, A. J., Mayo, M. W., Sartor, R. B., Baldwin, A. S., Jr. (1999). Interleukin-10 signaling blocks inhibitor of kappab kinase activity and nuclear factor kappab DNA binding. J. Biol. Chem. 274(45): 31868–31874.
   PubMed Web of Science ®Google Scholar
• Stringer, K. A., Serkova, N. J., Karnovsky, A., Guire, K., Paine, R. 3rd, Standiford, T. J. (2011). Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)h-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am. J. Physiol. Lung Cell Mol. Physiol. 300(1): L4–L11.
   Google Scholar
• Tseng, J. S., Chan, M. C., Hsu, J. Y., Kuo, B. I., Wu, C. L. (2008). Procalcitonin is a valuable prognostic marker in ards caused by community-acquired pneumonia. Respirology 13(4): 505–509.
   Google Scholar
• Uchida, T., Shirasawa, M., Ware, L. B., Kojima, K., Hata, Y., Makita, K., Mednick, G., Matthay, Z. A., Matthay, M. A. (2006). Receptor for advanced glycation end-products is a marker of type i cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 173(9): 1008–1015.
   PubMed Web of Science ®Google Scholar
• Van Meurs, M., Kumpers, P., Ligtenberg, J. J., Meertens, J. H., Molema, G., and Zijlstra, J. G. (2009). “Bench-to-bedside review: Angiopoietin signalling in critical illness — A future target?” Crit. Care 13(2): 207.
   PubMed Web of Science ®Google Scholar
• Wang, P., Wu, P., Siegel, M. I., Egan, R. W., Billah, M. M. (1995). Interleukin (il)-10 inhibits nuclear factor kappa b (nf kappa b) activation in human monocytes. Il-10 and il-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270(16): 9558–9563.
   PubMed Web of Science ®Google Scholar
• Wang, Z., Beach, D., Su, L., Zhai, R., Christiani, D. C. (2008). A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ards. Am. J. Respir. Cell Mol. Biol. 38(6): 724–732.
   PubMed Web of Science ®Google Scholar
• Ward, P. A. (1996). “Role of complement, chemokines, and regulatory cytokines in acute lung injury.” Ann. N.Y. Acad. Sci. 796: 104–112.
   PubMed Web of Science ®Google Scholar
• Ware, L. B. (2006). Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 27(4): 337–349.
   PubMed Web of Science ®Google Scholar
• Ware, L. B., Conner, E. R., Matthay, M. A. (2001). Von willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit. Care Med. 29(12): 2325–2331.
   PubMed Web of Science ®Google Scholar
• Ware, L. B., Kaner, R. J., Crystal, R. G., Schane, R., Trivedi, N. N., Mcauley, D., Matthay, M. A. (2005). Vegf levels in the alveolar compartment do not distinguish between ards and hydrostatic pulmonary oedema. Eur. Respir. J. 26(1): 101–105.
   PubMed Web of Science ®Google Scholar
• Ware, L. B., Koyama, T., Billheimer, D. D., Wu, W., Bernard, G. R., Thompson, B. T., Brower, R. G., Standiford, T. J., Martin, T. R., Matthay, M. A. (2010). Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2): 288–296.
   PubMed Web of Science ®Google Scholar
• Wu, C. L., Lin, L. Y., Yang, J. S., Chan, M. C., Hsueh, C. M. (2009). Attenuation of lipopolysaccharide-induced acute lung injury by treatment with il-10. Respirology 14(4): 511–521.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Lee, T. C., Guillemin, B., Yu, M. C., Rom, W. N. (1993). Enhanced il-1 beta and tumor necrosis factor-alpha release and messenger rna expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150(9): 4188–4196.
   PubMed Web of Science ®Google Scholar